{"Title": ["Health Care Sector Update for 06/11/2020: MBIO, SRNE, CCXI, VHT, IYH, XLV, IBB", "Noteworthy Thursday Option Activity: OLED, CCXI, ZUO", "ChemoCentryx Inc (CCXI) Q1 2020 Earnings Call Transcript", "Notable Wednesday Option Activity: OLED, CCXI, BYND", "7 \u201cPerfect 10\u201d Healthcare Stocks to Buy Now", "ChemoCentryx Inc (CCXI) Q4 2019 Earnings Call Transcript", "Notable Thursday Option Activity: CCXI, SQ, OLED", "Notable Monday Option Activity: CCXI, MHK, PAYC", "Health Care Sector Update for 06/11/2020: MBIO, SRNE, CCXI, VHT, IYH, XLV, IBB", "Here's Why ChemoCentryx Skyrocketed 278% Today", "Why Nutanix, Dick's Sporting Goods, and ChemoCentryx Jumped Today", "Noteworthy Tuesday Option Activity: PANW, CCXI, SSB", "ChemoCentryx (CCXI) Stock Could Hit $40, Says Analyst", "CCXI Is Red Hot, ZGNX On Watch, FDA Snubs ADMP", "Keep An Eye On FLGT, CCXI, ADBE\u2026", "ChemoCentryx Inc (CCXI) Q3 2019 Earnings Call Transcript", "ChemoCentryx Jumped by 348%. Is It a Buy?", "ChemoCentryx Inc (CCXI) Q2 2019 Earnings Call Transcript", "Why ChemoCentryx Shares Crashed 19.1% Today", "ChemoCentryx (CCXI) Looks Good: Stock Adds 5.5% in Session", "ChemoCentryx (CCXI) Q4 2018 Earnings Conference Call Transcript", "ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates", "After-Hours Earnings Report for March 11, 2019 : ADT, COUP, SFIX, DRNA, AVD, PETQ, CCXI, LXFR, MG, OXFD, FRTA, KALA", "ChemoCentryx (CCXI) Reports Q3 Loss, Lags Revenue Estimates", "Is This Small-Cap Biotech a Buy Before 2020?", "Health Care Sector Update for 09/28/2018: LLY,SPRO,CCXI,ALDX", "Health Care Sector Update for 09/28/2018: SPRO, CCXI, ALDX", "ChemoCentryx (CCXI) Reports Q2 Loss, Misses Revenue Estimates", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 7/15/2018", "Amgen Resubmits BLA to FDA for Osteoporosis Candidate Evenity", "J&J (JNJ) to Pay $4.69 Billion to Some Women in Talc Lawsuit", "Bristol-Myers' Combo Drugs Get FDA Nod for Colorectal Cancer", "Earnings Preview: ChemoCentryx (CCXI) Q3 Earnings Expected to Decline", "Health Care Sector Update for 09/28/2018: LLY,SPRO,CCXI,ALDX", "Health Care Sector Update for 09/28/2018: SPRO, CCXI, ALDX", "ChemoCentryx (CCXI) Reports Q2 Loss, Misses Revenue Estimates", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 7/15/2018", "Will ChemoCentryx (CCXI) Continue to Surge Higher?", "ChemoCentryx, 58.com, Seagate, Garmin and Texas Instruments as Zacks Bull and Bear of the Day", "Bull of the Day: ChemoCentryx (CCXI)", "KemPharm Stock Down Despite Positive Data on ADHD Candidate", "RedHill Gets Two New Patents for Crohn's Disease Candidate", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 6/17/2018", "4 Top-Ranked Nasdaq Stocks That Have Doubled This Year", "Stocks Still Rising at Start of Eventful Week", "TherapeuticsMD (TXMD) Soars: Stock Adds 9.1% in Session", "Nektar Therapeutics (NKTR) Jumps: Stock Rises 6.5%", "Can The Uptrend Continue for ChemoCentryx (CCXI)?", "Bear of the Day: 58.com (WUBA)", "ChemoCentryx (CCXI) Q4 2017 Earnings Conference Call Transcript", "Pre-Market Earnings Report for March 9, 2018 : BIG, AMWD, PRTY, REV, CCXI, CNTY, GWRS, ESES, MCF", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Mid-Day Market Update: Buckle Drops After December Sales Results; ChemoCentryx Shares Spike Higher", "Here's Why ChemoCentryx Rose as Much as 53.5% Today", "Mid-Morning Market Update: Markets Open Higher; Walgreens Earnings Top Views", "Health Care Sector Update for 01/04/2018: JNJ, PFE, ABT, MRK, AMGN, WBA, CVS, CCXI, CLSN, BOLD, ANGO, NSFTG", "Better Know Biotech: 2 Stocks You Ought to Know About", "ChemoCentryx (CCXI) Shares March Higher, Can It Continue?", "After-Hours Earnings Report for March 14, 2017 : HTHT, AKAO, CLDX, FOGO, NPTN, ARNA, CCXI, KURA, DRRX, CHMI, CNXR", "Friday Sector Leaders: Drugs, Biotechnology Stocks", "Health Care Sector Update for 10/18/2016: CCXI,ABEO,ICCC", "Can The Uptrend Continue for ChemoCentryx (CCXI)?", "ChemoCentryx (CCXI) Shows Strength: Stock Moves Up 42.4%", "Midday Update: Stocks Elevated by Higher Oil Prices, Strength in Europe", "ChemoCentryx (CCXI) Catches Eye: Stock Moves Up 6.4%", "Close Update: Higher Oil Fuels Wall Street Rally", "ChemoCentryx (CCXI) Shares March Higher, Can It Continue?", "ChemoCentryx's Q4 Loss Meet Estimates, Pipeline in Focus - Analyst Blog", "Can The Uptrend Continue for ChemoCentryx (CCXI)? - Tale of the Tape", "ChemoCentryx (CCXI) Shows Strength: Stock Moves Up 24.7% - Tale of the Tape", "ChemoCentryx Up on Positive Diabetic Nephropathy Data - Analyst Blog", "US Stocks to Open Lower as Oil, China Data Weighs on Sentiment", "Pre-Market Most Active for May 10, 2016 : NOK, CCXI, TVIX, AGN, GPS, LC, XIV, RIO, VRX, SCTY, ERIC, SNDK", "Futures Drop as Oil Slips Below $60, China Factory Output Slows", "Why ChemoCentryx Inc's Shares Shot 60% Higher Today", "ChemoCentryx (CCXI) Shows Strength: Stock Moves Up 5.6% - Tale of the Tape", "ChemoCentryx Drug Gets Orphan Designation in Europe - Analyst Blog", "ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape", "Why You Shouldn't Bet Against ChemoCentryx (CCXI) Stock - Tale of the Tape", "ChemoCentryx (CCXI) Jumps: Stock Up 5.7% - Tale of the Tape", "Pre-Market Most Active for Dec 12, 2014 : FCAU, TVIX, XIV, CCXI, QQQ, ARMK, BAC, SMFG, INFY, GPRO, AAPL, LYG", "Pre-Market Most Active for Dec 4, 2013 : JCP, EXPR, NOK, BAC, NCLH, QQQ, ALU, SAN, CCXI, TSLA, OMED, CLVS", "ChemoCentryx Inc. is now in Oversold Territory - Tale of the Tape", "Insiders at Puma Biotechnology, ChemoCentryx, and Ruby Tuesday Buy Shares", "Insiders Buy Shares at Achillion Pharmaceuticals, ChemoCentryx, and Walter Energy", "Insiders Bought Shares of ChemoCentryx, Hawaiian Holdings, and US Concrete", "Insiders Buy Shares at Fate Therapeutics and ChemoCentryx", "ChemoCentryx Inc Enters Oversold Territory - Tale of the Tape", "Positive Data on ChemoCentryx Candidate - Analyst Blog", "Pre-Market Most Active for Dec 4, 2013 : JCP, EXPR, NOK, BAC, NCLH, QQQ, ALU, SAN, CCXI, TSLA, OMED, CLVS", "ChemoCentryx Inc. is now in Oversold Territory - Tale of the Tape", "Sector Update: Healthcare", "Pipeline Setback for Glaxo - Analyst Blog", "ChemoCentryx Inc Enters Oversold Territory - Tale of the Tape", "After-Hours Earnings Report for August 12, 2013 : SINA, TRQ, IOC, IAG, WX, HMIN, TWGP, EGL, CCXI, FN, NQ, ACRX", "Wider-than-Expected Loss at ChemoCentryx - Analyst Blog", "ChemoCentryx Regains Rights to Vercirnon - Analyst Blog", "Pre-Market Most Active for Apr 17, 2013 : BAC, PBR, PBR/A, YHOO, QQQ, SNY, INTC, MTU, C, CRUS, CCXI, ASML", "ChemoCentryx quiet period ends March 19", "After-Hours Earnings Report for May 13, 2013 : CPA, IOC, POST, TTWO, WX, HMIN, CCXI, RENN, SVN, GOL, TEAR, FRF"], "Elapsed Time": ["JUN 11, 2020", "JUN 4, 2020", "MAY 12, 2020", "APR 29, 2020", "MAR 18, 2020", "MAR 11, 2020", "FEB 6, 2020", "JAN 6, 2020", "JUN 11, 2020", "NOV 26, 2019", "NOV 26, 2019", "NOV 26, 2019", "NOV 26, 2019", "NOV 26, 2019", "NOV 5, 2019", "NOV 4, 2019", "DEC 5, 2019", "AUG 8, 2019", "JUN 5, 2019", "MAR 19, 2019", "MAR 12, 2019", "MAR 11, 2019", "MAR 11, 2019", "NOV 8, 2018", "OCT 24, 2019", "SEP 28, 2018", "SEP 28, 2018", "AUG 9, 2018", "JUL 15, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 12, 2018", "OCT 30, 2018", "SEP 28, 2018", "SEP 28, 2018", "AUG 9, 2018", "JUN 29, 2018", "JUN 29, 2018", "JUN 22, 2018", "JUN 22, 2018", "JUL 10, 2018", "JUN 21, 2018", "JUN 17, 2018", "JUN 14, 2018", "JUN 12, 2018", "JUN 7, 2018", "JUN 6, 2018", "MAY 17, 2018", "JUN 22, 2018", "MAR 10, 2018", "MAR 8, 2018", "JAN 6, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 4, 2018", "MAY 16, 2018", "MAR 17, 2017", "MAR 14, 2017", "DEC 23, 2016", "OCT 18, 2016", "MAY 11, 2016", "MAY 11, 2016", "MAY 10, 2016", "JUL 12, 2017", "MAY 10, 2016", "DEC 2, 2015", "MAR 13, 2015", "DEC 15, 2014", "DEC 15, 2014", "DEC 15, 2014", "DEC 12, 2014", "MAY 10, 2016", "DEC 12, 2014", "DEC 12, 2014", "DEC 8, 2014", "DEC 5, 2014", "OCT 17, 2014", "APR 11, 2014", "JAN 2, 2014", "DEC 12, 2014", "DEC 4, 2013", "NOV 14, 2013", "NOV 7, 2013", "NOV 4, 2013", "OCT 11, 2013", "OCT 8, 2013", "SEP 23, 2013", "DEC 5, 2013", "DEC 4, 2013", "NOV 14, 2013", "SEP 10, 2013", "AUG 26, 2013", "AUG 21, 2013", "AUG 12, 2013", "MAY 14, 2013", "SEP 19, 2013", "APR 17, 2013", "MAR 14, 2012", "MAY 13, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/health-care-sector-update-for-06-11-2020%3A-mbio-srne-ccxi-vht-iyh-xlv-ibb-2020-06-11", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-oled-ccxi-zuo-2020-06-04", "https://www.nasdaq.com/articles/chemocentryx-inc-ccxi-q1-2020-earnings-call-transcript-2020-05-12", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-oled-ccxi-bynd-2020-04-29", "https://www.nasdaq.com/articles/7-perfect-10-healthcare-stocks-to-buy-now-2020-03-18", "https://www.nasdaq.com/articles/chemocentryx-inc-ccxi-q4-2019-earnings-call-transcript-2020-03-11", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-ccxi-sq-oled-2020-02-06", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-ccxi-mhk-payc-2020-01-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-11-2020%3A-mbio-srne-ccxi-vht-iyh-xlv-ibb-2020-06-11", "https://www.nasdaq.com/articles/heres-why-chemocentryx-skyrocketed-278-today-2019-11-26", "https://www.nasdaq.com/articles/why-nutanix-dicks-sporting-goods-and-chemocentryx-jumped-today-2019-11-26", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-panw-ccxi-ssb-2019-11-26", "https://www.nasdaq.com/articles/chemocentryx-ccxi-stock-could-hit-%2440-says-analyst-2019-11-26", "https://www.nasdaq.com/articles/ccxi-is-red-hot-zgnx-on-watch-fda-snubs-admp-2019-11-26", "https://www.nasdaq.com/articles/keep-an-eye-on-flgt-ccxi-adbe...-2019-11-05", "https://www.nasdaq.com/articles/chemocentryx-inc-ccxi-q3-2019-earnings-call-transcript-2019-11-05", "https://www.nasdaq.com/articles/chemocentryx-jumped-by-348.-is-it-a-buy-2019-12-05", "https://www.nasdaq.com/articles/chemocentryx-inc-ccxi-q2-2019-earnings-call-transcript-2019-08-08", "https://www.nasdaq.com/articles/why-chemocentryx-shares-crashed-19.1-today-2019-06-05", "https://www.nasdaq.com/articles/chemocentryx-ccxi-looks-good%3A-stock-adds-5.5-in-session-2019-03-19", "https://www.nasdaq.com/articles/chemocentryx-ccxi-q4-2018-earnings-conference-call-transcript-2019-03-12", "https://www.nasdaq.com/articles/chemocentryx-ccxi-reports-q4-loss-lags-revenue-estimates-2019-03-11", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-11-2019-adt-coup-sfix-drna-avd-petq-ccxi-lxfr-mg-oxfd", "https://www.nasdaq.com/articles/chemocentryx-ccxi-reports-q3-loss-lags-revenue-estimates-2018-11-08", "https://www.nasdaq.com/articles/is-this-small-cap-biotech-a-buy-before-2020-2019-10-24", "https://www.nasdaq.com/articles/health-care-sector-update-09282018-llysproccxialdx-2018-09-28", "https://www.nasdaq.com/articles/health-care-sector-update-09282018-spro-ccxi-aldx-2018-09-28", "https://www.nasdaq.com/articles/chemocentryx-ccxi-reports-q2-loss-misses-revenue-estimates-2018-08-09", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-kenneth-fisher-7152018-2018-07-15", "https://www.nasdaq.com/articles/amgen-resubmits-bla-to-fda-for-osteoporosis-candidate-evenity-2018-07-13", "https://www.nasdaq.com/articles/jj-jnj-to-pay-%244.69-billion-to-some-women-in-talc-lawsuit-2018-07-13", "https://www.nasdaq.com/articles/bristol-myers-combo-drugs-get-fda-nod-for-colorectal-cancer-2018-07-12", "https://www.nasdaq.com/articles/earnings-preview%3A-chemocentryx-ccxi-q3-earnings-expected-to-decline-2018-10-30", "https://www.nasdaq.com/articles/health-care-sector-update-09282018-llysproccxialdx-2018-09-28", "https://www.nasdaq.com/articles/health-care-sector-update-09282018-spro-ccxi-aldx-2018-09-28", "https://www.nasdaq.com/articles/chemocentryx-ccxi-reports-q2-loss-misses-revenue-estimates-2018-08-09", "https://www.nasdaq.com/articles/7-stocks-with-recent-price-strength-to-enhance-your-returns-2018-06-29", "https://www.nasdaq.com/articles/will-chemocentryx-ccxi-continue-to-surge-higher-2018-06-29", "https://www.nasdaq.com/articles/chemocentryx-58.com-seagate-garmin-and-texas-instruments-as-zacks-bull-and-bear-of-the-day", "https://www.nasdaq.com/articles/bull-day-chemocentryx-ccxi-2018-06-22", "https://www.nasdaq.com/articles/kempharm-stock-down-despite-positive-data-on-adhd-candidate-2018-07-10", "https://www.nasdaq.com/articles/ptc-therapeutics-ptct-jumps%3A-stock-rises-7.2-2018-06-21", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-kenneth-fisher-6172018-2018-06-17", "https://www.nasdaq.com/articles/4-top-ranked-nasdaq-stocks-that-have-doubled-this-year-2018-06-14", "https://www.nasdaq.com/articles/stocks-still-rising-start-eventful-week-2018-06-12", "https://www.nasdaq.com/articles/therapeuticsmd-txmd-soars%3A-stock-adds-9.1-in-session-2018-06-07", "https://www.nasdaq.com/articles/nektar-therapeutics-nktr-jumps%3A-stock-rises-6.5-2018-06-06", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-chemocentryx-ccxi-2018-05-17", "https://www.nasdaq.com/articles/bear-day-58com-wuba-2018-06-22", "https://www.nasdaq.com/articles/chemocentryx-ccxi-q4-2017-earnings-conference-call-transcript-2018-03-10", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-9-2018-big-amwd-prty-rev-ccxi-cnty-gwrs-eses-mcf-2018-03", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-01-06", "https://www.nasdaq.com/articles/mid-day-market-update-buckle-drops-after-december-sales-results-chemocentryx-shares-spike", "https://www.nasdaq.com/articles/heres-why-chemocentryx-rose-much-535-today-2018-01-04", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-walgreens-earnings-top-views-2018-01-04", "https://www.nasdaq.com/articles/health-care-sector-update-01042018-jnj-pfe-abt-mrk-amgn-wba-cvs-ccxi-clsn-bold-ango-nsftg", "https://www.nasdaq.com/articles/better-know-biotech-2-stocks-you-ought-know-about-2018-05-16", "https://www.nasdaq.com/articles/chemocentryx-ccxi-shares-march-higher-can-it-continue-2017-03-17", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-14-2017-htht-akao-cldx-fogo-nptn-arna-ccxi-kura-drrx", "https://www.nasdaq.com/articles/friday-sector-leaders-drugs-biotechnology-stocks-2016-12-23", "https://www.nasdaq.com/articles/health-care-sector-update-10182016-ccxiabeoiccc-2016-10-18", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-chemocentryx-ccxi-2016-05-11", "https://www.nasdaq.com/articles/chemocentryx-ccxi-shows-strength%3A-stock-moves-up-42.4-2016-05-11", "https://www.nasdaq.com/articles/midday-update-stocks-elevated-higher-oil-prices-strength-europe-2016-05-10", "https://www.nasdaq.com/articles/chemocentryx-ccxi-catches-eye%3A-stock-moves-up-6.4-2017-07-12", "https://www.nasdaq.com/articles/close-update-higher-oil-fuels-wall-street-rally-2016-05-10", "https://www.nasdaq.com/articles/chemocentryx-ccxi-shares-march-higher-can-it-continue-2015-12-02", "https://www.nasdaq.com/articles/chemocentryxs-q4-loss-meet-estimates-pipeline-in-focus-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-chemocentryx-ccxi-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/chemocentryx-ccxi-shows-strength%3A-stock-moves-up-24.7-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/chemocentryx-up-on-positive-diabetic-nephropathy-data-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/us-stocks-open-lower-oil-china-data-weighs-sentiment-2014-12-12", "https://www.nasdaq.com/articles/pre-market-most-active-may-10-2016-nok-ccxi-tvix-agn-gps-lc-xiv-rio-vrx-scty-eric-sndk", "https://www.nasdaq.com/articles/futures-drop-oil-slips-below-60-china-factory-output-slows-2014-12-12", "https://www.nasdaq.com/articles/why-chemocentryx-incs-shares-shot-60-higher-today-2014-12-12", "https://www.nasdaq.com/articles/chemocentryx-ccxi-shows-strength%3A-stock-moves-up-5.6-tale-of-the-tape-2014-12-08", "https://www.nasdaq.com/articles/chemocentryx-drug-gets-orphan-designation-in-europe-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/chemocentryx-inc.-ccxi-in-focus%3A-stock-rises-9.6-tale-of-the-tape-2014-10-17", "https://www.nasdaq.com/articles/why-you-shouldnt-bet-against-chemocentryx-ccxi-stock-tale-of-the-tape-2014-04-11", "https://www.nasdaq.com/articles/chemocentryx-ccxi-jumps%3A-stock-up-5.7-tale-of-the-tape-2014-01-02", "https://www.nasdaq.com/articles/pre-market-most-active-dec-12-2014-fcau-tvix-xiv-ccxi-qqq-armk-bac-smfg-infy-gpro-aapl-lyg", "https://www.nasdaq.com/articles/pre-market-most-active-dec-4-2013-jcp-expr-nok-bac-nclh-qqq-alu-san-ccxi-tsla-omed-clvs", "https://www.nasdaq.com/articles/chemocentryx-inc.-is-now-in-oversold-territory-tale-of-the-tape-2013-11-14", "https://www.nasdaq.com/articles/insiders-puma-biotechnology-chemocentryx-and-ruby-tuesday-buy-shares-2013-11-07", "https://www.nasdaq.com/articles/insiders-buy-shares-achillion-pharmaceuticals-chemocentryx-and-walter-energy-2013-11-04", "https://www.nasdaq.com/articles/insiders-bought-shares-chemocentryx-hawaiian-holdings-and-us-concrete-2013-10-11", "https://www.nasdaq.com/articles/insiders-buy-shares-fate-therapeutics-and-chemocentryx-2013-10-08", "https://www.nasdaq.com/articles/chemocentryx-inc-enters-oversold-territory-tale-of-the-tape-2013-09-23", "https://www.nasdaq.com/articles/positive-data-on-chemocentryx-candidate-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/pre-market-most-active-dec-4-2013-jcp-expr-nok-bac-nclh-qqq-alu-san-ccxi-tsla-omed-clvs", "https://www.nasdaq.com/articles/healthcare-stocks-posting-moderate-gains-chemocentryx-falls-22-getting-no-help-new-drug", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-09-10", "https://www.nasdaq.com/articles/pipeline-setback-for-glaxo-analyst-blog-2013-08-26", "https://www.nasdaq.com/articles/chemocentryx-inc-enters-oversold-territory-tale-of-the-tape-2013-08-21", "https://www.nasdaq.com/articles/after-hours-earnings-report-august-12-2013-sina-trq-ioc-iag-wx-hmin-twgp-egl-ccxi-fn-nq", "https://www.nasdaq.com/articles/wider-than-expected-loss-at-chemocentryx-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/chemocentryx-regains-rights-to-vercirnon-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/pre-market-most-active-apr-17-2013-bac-pbr-pbra-yhoo-qqq-sny-intc-mtu-c-crus-ccxi-asml", "https://www.nasdaq.com/articles/chemocentryx-quiet-period-ends-march-19-2012-03-14", "https://www.nasdaq.com/articles/after-hours-earnings-report-may-13-2013-cpa-ioc-post-ttwo-wx-hmin-ccxi-renn-svn-gol-tear"], "Content": []}